The right patient. The right treatment.
No room for manipulated results.
Ruma Digital-System (Pro) provides manipulation resistant verification, linking the member, the specimen and the laboratory result - so the care you fund is based on real evidence, not a misleading sample.
1
2
Commercial Health Plans
Private health insurers
Don't let someone else's result drive youor member's treatment
Ruma Digtal-System (Pro) strenthens specimen attribution so clinical teams make treatment decisions using results linked to the person they are treating.
Medicaid Plans & Public Payers
State programs and MCOs
Public dollars should support actual care needs - not a misleading picture of progress
Use Ruma Digtal-System (Pro)'s verification to strengthen the evidence informing publicly funded treatment, rather than relying on an unverified speecimen source.
Behavioral Health Organizations & Benefit Managers
Private health insurers
Build consistency across your care network - not uncertainty between providers
Establish a shared specimen-verification process with Ruma Digital-System (Pro) so treatment partners can coordinate care using results traceable to the member.
Self-Funded Employer Health Plans
Private health insurers
Protect your healthcare investment - not a misleading picture of progress
Ruma Digtal-System (Pro) supports better-informed treatment decisions within the health plan's clinical care pathway, keeping the focus on member care - not workplace screeing.
Medicare Advantage Plans
Private health insurers
Complex care need evidence tied to the right person.
For members receiving substance-use care, Ruma Digital-System (Pro) adds verified specimen attribution to support coordinated decisions across their treatinng teams.
The wrong specimen can send care in the wrong direction.
Protect the evidence behind the care you fund.
A drug-negative result from someone else’s specimen can hide the member’s actual substance use. The result may be accurate. Its attribution is not.
RUMA adds manipulation-resistant verification linking the member to the specimen and laboratory result—through documented, professionally reviewed one-time marker intake and laboratory marker detection.
Test results support—not replace—clinical assessment. Clinical and economic benefits require evaluation in the intended care setting.
Strengthen the basis for treatment decisions.
Give care teams greater confidence that the result belongs to the person they are treating.
Put care resources where they are needed.
Make verified specimen attribution part of the evidence informing the care you fund.
Verify who the result belongs to. Protect the care it informs.
Protect the evidence behind the care you fund.
A result from the wrong person can point care in the wrong direction. RUMA adds manipulation-resistant verification linking the member, the specimen and the laboratory result—strengthening the evidence behind treatment decisions.
Commercial Health Plans
Right patient. Right result. Right treatment.
RUMA helps ensure that treatment decisions are based on results that can be reliably linked to the member being treated.
Medicaid Plans & Public Payers
Public funding deserves verified evidence.
RUMA helps ensure that treatment decisions and care resources are based on results that can be reliably attributed to the person receiving care.
Behavioral Health Organizations & Benefit Managers
Stop passing uncertainty through the care network.
RUMA creates a consistent verification layer across treatment partners, helping ensure that every provider works from results linked to the right person.
Self-Funded Employer Health Plans
Stop funding care on uncertain evidence.
RUMA adds verified specimen attribution so treatment dollars are guided by results linked to the right member—not by an unverified sample.
Medicare Advantage Plans
One wrong attribution can misdirect an entire care pathway.
RUMA adds verified specimen attribution so every treating team works from evidence tied to the right member.
